Navigation Links
Nova Oculus Enlists Intertek to Audit ISO Certification Process

Nova Oculus Partners has taken another critical step towards achieving full commercialization for the electrotherapeutic device it’s developing to treat the dry version of Age-Related Macular Degeneration.

Chief operating officer Walter O’Rourke has announced the company has signed an agreement with the Intertek Group PLC to help guide its pioneering Nova Oculus device toward ISO certification worldwide. The ISO (International Organization of Standardization) establishes the criteria for companies to follow so their medical devices can be certified for adhering to a comprehensive quality management system in their engineering and development.

Intertek, which is based in the U.K., employs more than 42,000 people in 100 countries to assist companies such as Nova Oculus in the testing and inspection of their products so they can achieve ISO certification.

As reported recently, Nova Oculus has also engaged the Emergo Group, a global regulatory consultancy, to help with that process. Their work set the stage for Intertek to conduct a certification audit of our medical device’s development so it can be sanctioned by the ISO.

According to O’Rourke, this is how the process works. “Emergo will help us to define regulatory requirements in every country where we are seeking to commercialize our device and assist us in developing our ISO systems,” he said.

“Emergo will help enter new markets and to make sure we are prepared for the Intertek audits. Intertek will provide the actual audits that allow us to obtain and maintain the certifications we require.”

It is estimated that more than 40 million people in the U.S., Canada, Britain, the EU, Japan and Australia are afflicted with AMD, and are either blind or at risk for becoming blind.

About Nova Oculus Partners:

Nova Oculus Partners, LLC was formed to develop, manufacture, and lease to medical professionals an electrotherapeutic medical device to mitigate the effects of the dry version of Age-Related Macular Degeneration. It would do so by providing a pulsed micro-current output to the retina through a closed eyelid.

The Nova Oculus company’s pulsed micro-current therapy represents a new, non-invasive treatment for the dry version of AMD. The device output signal is structured to provide a range and pattern of frequencies to stimulate the desired physiologic response at the retinal level. This low current has been shown by studies to stimulate the production of the active transport enzyme, adenosine triphosphate (ATP), which facilitates the movement of nutrition from the blood to the cell.

According to recent studies, this treatment improves permeability of the blood vessel membranes and cells, allows better oxygen and nutrition delivery to the cells, metabolism, and removal of by-products from the cells. Through these mechanisms, pulsed micro-current therapy improves retinal pigment epithelium (RPE) efficiency and in so doing may restore and/or improve retinal function.

For more information contact:
Walter O’Rourke,
Chief Operating Officer

Read the full story at

Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved

Related biology technology :

1. Nova Oculus Recruits Emergo to Assist with Global Compliance
2. uBiome Joins Google, SpaceX, and Oculus as 2016 World Technology Award Finalist
3. Cancer, Meet the Alamo: San Antonio Enlists WuXi NextCODE to Speed Unparalleled Open-access Cancer Genome Project
4. ComplianceOnline Announces Seminar on Pharmacovigilance Audit Strategy Planning
5. MiMedx Audit Committee Announces Completion Of Its Investigation
6. Superior Controls Announces Passing 50th Consecutive Biotech Supplier FDA-Required Quality Audit
7. ValGenesis Inc. Successfully Completes ISO 9001:2008 Surveillance Audit
8. Origin Agritech Limited Reports Unaudited Financial Results For Three Months Ended December 31, 2015
9. Origin Agritech Limited Reports Unaudited Financial Results For the Year Ended September 30, 2015
10. Sinovac Reports Unaudited Third Quarter Financial Results
11. Sinovac to Host Conference Call to Report Third Quarter 2015 Unaudited Financial Results
Post Your Comments:
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
(Date:10/10/2017)... SANTA BARBARA, CALIFORNIA (PRWEB) , ... October 10, ... ... risk management, technological innovation and business process optimization firm for the life sciences ... the BoxWorks conference in San Francisco. , The presentation, “Automating GxP ...
(Date:10/9/2017)... ... 2017 , ... The Giving Tree Wellness Center announces the ... of consumers who are incorporating medical marijuana into their wellness and health regimens. ... operators of two successful Valley dispensaries, The Giving Tree’s two founders, Lilach Mazor ...
(Date:10/6/2017)... ... October 06, 2017 , ... The ... and technology sector at their fourth annual Conference where founders, investors, innovative practitioners ... and the ELEVATE pitch competition showcasing early stage digital health and med tech ...
Breaking Biology Technology:
(Date:4/24/2017)... 24, 2017 Janice Kephart , ... Identity Strategy Partners, LLP (IdSP) , today issues ... President Trump,s March 6, 2017 Executive Order: ... vetting can be instilled with greater confidence, enabling ... all refugee applications are suspended by until at ...
(Date:4/13/2017)... UBM,s Advanced Design and Manufacturing event in ... and evolving technology through its 3D Printing and Smart ... the expo portion of the event and feature a ... on trending topics within 3D printing and smart manufacturing. ... will take place June 13-15, 2017 at the Jacob K. ...
(Date:4/11/2017)... , April 11, 2017 No two ... researchers at the New York University Tandon School ... Engineering have found that partial similarities between prints ... used in mobile phones and other electronic devices ... The vulnerability lies in the fact that ...
Breaking Biology News(10 mins):